Phase I dose escalation study of E7080, a novel anti-angiogenic multikinase inhibitor, in Japanese patients with advanced solid tumors

被引：0
|
作者：
Yamada, K. [1 ]
Fujiwara, Y. [1 ]
Yamamoto, N. [1 ]
Yamada, Y. [1 ]
Suzuki, S. [1 ]
Kobayashi, N. [1 ]
Koizumi, F. [1 ]
Nishio, K. [1 ]
Tamura, T. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14099
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I dose-escalation study of E7080, a multikinase inhibitor, in patients with advanced solid tumors
    Nemunaitis, J. J.
    Senzer, N. N.
    Kurzrock, R.
    Ng, C. S.
    Das, A.
    Atienza, R. S.
    Zang, E. A.
    Jansen, M.
    Ashworth, S.
    Hong, D. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Phase I dose escalation study and biomarker analysis of E7080 in patients with advanced solid tumors
    Yamada, K.
    Hirata, T.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Yamada, Y.
    Koizumi, F.
    Nishio, K.
    Koyama, N.
    Tamura, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
    Yamada, Kazuhiko
    Yamamoto, Noboru
    Yamada, Yasuhide
    Nokihara, Hiroshi
    Fujiwara, Yutaka
    Hirata, Taizo
    Koizumi, Fumiaki
    Nishio, Kazuto
    Koyama, Noriyuki
    Tamura, Tomohide
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2528 - 2537
  • [4] A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Yamamoto, N.
    Nokihara, H.
    Yamada, Y.
    Honda, K.
    Wakui, H.
    Sasaki, T.
    Yusa, W.
    Tamura, T.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [5] Phase I dose-escalation study of E7080, a selective tyrosine kinase inhibitor, administered orally to patients with solid tumors.
    Hong, D. S.
    Koetz, B. S.
    Kurzrock, R.
    Senzer, N. N.
    Hanekom, W.
    Naing, A.
    Wheler, J. J.
    Mink, J.
    Ren, M.
    Nemunaitis, J. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
    Boss, D. S.
    Glen, H.
    Beijnen, J. H.
    Keesen, M.
    Morrison, R.
    Tait, B.
    Copalu, W.
    Mazur, A.
    Wanders, J.
    O'Brien, J. P.
    Schellens, J. H. M.
    Evans, T. R. J.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (10) : 1598 - 1604
  • [7] A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
    D S Boss
    H Glen
    J H Beijnen
    M Keesen
    R Morrison
    B Tait
    W Copalu
    A Mazur
    J Wanders
    J P O'Brien
    J H M Schellens
    T R J Evans
    [J]. British Journal of Cancer, 2012, 106 : 1598 - 1604
  • [8] A phase I dose finding study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D.
    Evans, T. R.
    Roelvink, M.
    Saro, J. M.
    Bezodis, P.
    Copalu, W.
    Das, A.
    Crosswell, G.
    Schellens, J. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] A phase I study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D. R.
    Morrison, R.
    Roelvink, M.
    Wanders, J.
    Mazur, A.
    Gupta, A.
    Das, A.
    Evans, T. R.
    Schellens, J. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma
    Hong, David S.
    Kurzrock, Razelle
    Wheler, Jennifer J.
    Naing, Aung
    Falchook, Gerald S.
    Fu, Siqing
    Kim, Kevin B.
    Davies, Michael A.
    Nguyen, Ly M.
    George, Goldy C.
    Xu, Lucy
    Shumaker, Robert
    Ren, Min
    Mink, Jennifer
    Bedell, Cynthia
    Andresen, Corina
    Sachdev, Pallavi
    O'Brien, James P.
    Nemunaitis, John
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (21) : 4801 - 4810
12345